ERBB2 and breast carcinoma: The main subtypes of breast cancer are divided by the expression statuses of three tumor markers evaluated comprehensively and routinely because of their application in guiding clinical treatment: estrogen receptor, progesterone receptor and human epidermal growth factor 2-neu (HER2).